Roche partners with Chinese startup for drug discovery in nearly $1 billion deal
Roche has entered into a collaboration worth close to $1 billion with Chinese biotech startup Defand Therapeutics, as reported by Stat News. The partnership aims at discovering new medicines and marks Roche's continued investment in innovative research through strategic alliances. Defand Therapeutics confirmed the agreement but did not provide further details on specific therapeutic areas or timelines for drug development under this collaboration. This move aligns with broader industry trends of pharmaceutical giants partnering with agile biotech firms to accelerate innovation.
Tickers: $ROP
Topics: collaboration pharma R&D investment